cyclosporine and Duncan Disease

cyclosporine has been researched along with Duncan Disease in 138 studies

Research

Studies (138)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.72)	18.7374
1990's	52 (37.68)	18.2507
2000's	54 (39.13)	29.6817
2010's	29 (21.01)	24.3611
2020's	2 (1.45)	2.80

Authors

Authors	Studies
Amini, L; Anft, M; Babel, N; Blàzquez-Navarro, A; Choi, M; Hecht, J; Nienen, M; Reinke, P; Roch, T; Schmueck-Henneresse, M; Schulz, M; Stervbo, U; Stittrich, AB; Thieme, CJ; Viebahn, R; Wehler, P; Westhoff, TH; Zgoura, P	1
Azzali, A; Bigagli, E; Ciullini Mannurita, S; Coniglio, ML; D'Elios, MM; Favre, C; Fotzi, I; Frenos, S; Gambineri, E; Goda, R; Grassi, A; Luceri, C; Sanvito, MC; Schiavo, E; Tintori, V; Tondo, A; Vignoli, M	1
Dimitrova, M; Jovanovska, RP; Kostova, NM; Serafimoski, V; Stardelova, KG; Stavrik, S; Stojanovik, A	1
Kaden, J; Völp, A; Wesslau, C	1
Bader-Meunier, B; Bodemer, C; Brochard, K; Fraitag, S; Janssen, C; Lamant, L; Wouters, C	1
Imashuku, S; Kubo, K; Kudo, N; Yachie, A	1
Bresnahan, B; Gaite, LE; Gang, S; Grinyó, J; Kothari, J; Larsen, CP; Moal, MC; Mondragón-Ramirez, GA; Pupim, L; Rice, KM; Rostaing, L; Steinberg, S; Vincenti, F	1
Riella, LV; Sayegh, MH	1
Charpentier, B; Del C Rial, M; Florman, S; Grinyó, J; Matas, A; Medina Pestana, JO; Mühlbacher, F; Pupim, L; Rostaing, L; Vanrenterghem, Y; Zhang, R	1
Martin, ST; Patel, M; Powell, JT; Tsapepas, D	1
Nakao, S	1
Chapman, JR; Craig, JC; Henderson, L; Masson, P; Webster, AC	1
Budde, K; Busque, S; Chan, G; Lamba, M; Lawendy, N; O'Connell, PJ; Russ, G; Silva, HT; Tortorici, MA; Vincenti, F; Wang, W; Yoshida, A	1
Al-Musa, A; Duran-Struuck, R; Hanekamp, I; Huang, CA; Matar, AJ; Patil, AR; Sachs, DH	1
Basiaga, ML; Behrens, EM; Weiss, PF	1
Åhlin, A; Hagelberg, S; Olsson, RF; Ringdén, O; Schiller, B; Truedsson, L	1
Alberu, J; Del Carmen Rial, M; Grinyó, JM; Jones-Burton, C; Kamar, N; Manfro, RC; Nainan, G; Steinberg, SM; Vincenti, F	1
Fisher, RI; Gordon, LI; Grogan, TM; Kasamon, Y; LeBlanc, M; Miller, AM; Miller, TP; Stiff, PJ; Swinnen, LJ	1
Clemares, M; Jiménez, C; Manrique, A; Marqués, E; Moreno, E; Ortega, P; Vallejo, GH	1
Elidemir, O; Heinle, JS; Kancherla, BS; Mallory, GB; McKenzie, ED; Morales, DL; Schecter, MG	1
Chan, KC; Cheng, FW; Lee, V; Li, CK; Shing, MK; To, KF	1
Amrolia, PJ; Brewin, J; Karlsson, H; Mancao, C; Pule, M; Samarasinghe, S; Straathof, K	1
Chang, HH; Chen, IM; Chen, PL; Hsieh, YC; Lai, ST; Shih, CC; Weng, ZC; Yang, AH	1
Allen, U; Clarizia, NA; Dipchand, AI; Holmes, C; Manlhiot, C; McCrindle, BW; Ngan, BY; Pollock-Barziv, SM; Weitzman, S	1
Agarwal, M; Bresnahan, B; Charpentier, B; Darji, P; Di Russo, G; Garg, P; Larsen, CP; Lin, CS; Massari, P; Mondragon-Ramirez, GA; Rostaing, L; Vanrenterghem, Y; Vincenti, F	1
Andrade, WC; Ayoub, AA; Gibelli, NE; Lima, F; Maksoud-Filho, JG; Mello, ES; Miyatani, HT; Pinho-Apezzato, ML; Santos, MM; Silva, MM; Tannuri, AC; Tannuri, U; Velhote, MC	1
Block, A; Breshahan, B; Campistol, JM; Charpentier, B; Di Russo, G; Florman, S; Garg, P; Grinyó, J; Kamar, N; Larsen, CP; Lin, CS; Medina-Pestana, J; Rial, Mdel C; Vanrenterghem, Y; Vincenti, F	1
Addonizio, LJ; Dayton, JD; Orjuela, M; Richmond, ME; Shipp, AT; Weintraub, RG	1
Fujikawa, T; Fujita, S; Hemming, AW; Kim, RD; Mizuno, S; Schwartz, JJ; Sorensen, JB	1
Khalpey, Z; Kushwaha, SS; Miller, DV; Schmitto, JD	1
Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K	1
Bunnapradist, S; Cho, YW; Hutchinson, IV; Sampaio, MS; Shah, T	1
Iwaki, N; Kondo, Y; Kotani, T; Nakao, S; Ohata, K; Yamazaki, H	1
Akahane, D; Asano, N; Ichikawa, N; Kobayashi, H; Sato, K; Shimizu, I; Sumi, M; Ueki, T; Ueno, M; Watanabe, M	1
Becker, T; Block, A; Campistol, JM; Duan, T; Durrbach, A; Florman, S; Garcia, VD; Grinyo, JM; Harler, MB; Kamar, N; Lang, P; Manfro, RC; Massari, P; Pestana, JO; Rial, MD; Schnitzler, MA; Vanrenterghem, Y; Vitko, S	1
Alobeid, B; Bhagat, G; Fang, Y; Gindin, T; Lee, JC; Pinkney, KA; Weiner, MA	1
Arnan, M; Bermúdez, A; Caballero, T; Duarte, RF; Montes, C; Patiño, B; Sánchez-Ortega, I; Vázquez, L; Yáñez, L	1
Allgood, JW; Bodensteiner, DM; Cook, JD; Deauna-Limayo, D; Ellis, RJ; Kahn, Q; Mayo, MS; Skikne, BS	1
Broering, DC; Burdelski, M; Ganschow, R; Meyer, T; Schulz, T	2
Berquist, R; Berquist, W; Cox, K; Esquivel, C; Millan, M; Zajicek, A	1
Gordon, KB; McClure, SL; Valentine, J	1
Caballero, D; Chopra, R; Craddock, C; García-Conde, J; Goldstone, AH; Hunter, A; Kottaridis, PD; Leon, A; Linch, DC; Mackinnon, S; Martino, R; Milligan, DW; Parker, A; Pérez-Simón, JA; San Miguel, JF; Schey, S; Sierra, J; Sureda, A; Urbano-Ispizua, A; Yong, K	1
Chaparro, SV; DiMiceli, S; Gao, SZ; Hastie, T; Miller, JL; Montoya, JG; Oyer, PE; Perlroth, M; Schroeder, J	1
Chan, MC; Gao, SZ; Hunt, SA; Robbins, RC; Shiba, N; Valantine, HA	1
Cherikh, WS; Hanto, DW; Kauffman, HM; Maghirang, J; McBride, MA; Swinnen, LJ	1
Cameron, AM; Cho, PS; Cina, RA; Coburn, RC; Fishman, JA; Hettiaratchy, S; Huang, CA; Melendy, E; Mueller, NJ; Neville, DM; Patience, C; Sachs, DH	1
Campana, C; Cavallini, D; Incardona, P; Ippoliti, G; Lucioni, M; Magrini, U; Paulli, M; Riboni, R; Viganò, M; Viglio, A	1
Adle-Biassette, H; Gaulard, P; Lelièvre, JD; Molinier-Frenkel, V; Papo, T; Sacre, K	1
Khaghani, A; Smith, RR; Wray, J; Yacoub, M	1
Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N	1
Brown, L; Cheung, D; Prabhakaran, V; Sampath, R; Stitson, RN	1
Fischer, G; Fritsch, G; Gadner, H; Lawitschka, A; Lion, T; Matthes-Martin, S; Peters, C; Pötschger, U; Rosenmayr, A; Seidel, MG	1
Buell, JF; Gross, TG; Woodle, ES	1
Bader, P; Boppana, S; Dormann, S; Fisch, P; Goebel, H; Jung, A; Kontny, U; Niemeyer, C; Peters, A; Strahm, B; Werner, M	1
Bernstein, D; Burge, M; Chin, C; Gamberg, P; Kouretas, P; Miller, J; Reitz, B; Robbins, R; Ross, M	1
Bradstock, KF; Gottlieb, D; Grigg, A; Hertzberg, M; Hoyt, R; Huang, G; Roberts, A; Szer, J	1
Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA	1
Wang, CZ; Wei, P; Zhang, SH; Zhang, YN; Zheng, YY; Zhou, XG	1
Andreone, P; Baccarani, M; Bernardi, M; Gramenzi, A; Grazi, GL; Lorenzini, S; Morelli, C; Pileri, S; Tura, S; Zinzani, PL	1
Emery, H; Grenert, J; Hermiston, M; Lam, W; Modica, R; von Scheven, E; Wirt, M	1
Banner, NR; Burke, MM; Hamour, IM; Lyster, HS; Rose, ML	1
Campistol, JM; Gutiérrez-Dalmau, A	1
Chen, J; Li, JP; Zhang, T; Zhong, J; Zhu, KE	1
Dantal, J; Pohanka, E	1
Irshad, FA; Onciu, MM; Walton, RC; Wilson, TD	1
Li, L; Zhang, YM; Zhu, ZJ	1
Blanche, S; de Saint Basile, G; Fischer, A; Mahlaoui, N; Neven, B; Ouachée-Chardin, M; Picard, C	1
Járay, J; Végso, G	1
Arar, M; Bridges, N; Grimm, P; Harmon, W; Ho, M; Ikle, D; Liereman, D; Lindblad, R; McDonald, RA; Smith, JM; Wyatt, R	1
Hanke, C; Jüttner, E; Lauten, M; Niemeyer, CM; Pohl, M; Rohr, JC; Wacker, HH; Wagner, HJ	1
Leleiko, N; LeLeiko, VM; Miller, CM; Moran, V; Rosh, JR; Schwartz, M; Schwersenz, AH	1
Ascari, E; Balduzzi, P; Incardona, S; Ippoliti, G; Lorenzutti, F; Martinelli, L; Negri, M; Rovati, B; Viganò, M	1
Berquist, WE; Cox, KL; Esquivel, CO; Garcia-Kennedy, R; Krams, SM; Lawrence-Miyasaki, LS; Lennette, ET; Martinez, OM; So, SK	1
Armitage, JM; Fricker, FJ; Swenson, JM	1
Arseniev, L; Bähre, O; Battmer, K; Berenson, RJ; Casper, J; Diedrich, H; Jacobs, R; Kadar, JG; Kühl, J; Link, H; Poliwoda, H; Schubert, J	1
Armitage, J; Fung, JJ; Jordan, M; McCauley, J; Nour, B; Reyes, J; Shapiro, R; Starzl, TE; Todo, S; Tzakis, AG	1
Armitage, JM; del Nido, P; Fricker, FJ; Griffith, BP; Hardesty, RL; Starzl, TE	1
Allison, JP; Davidson, WF; Giese, T	1
Billingham, ME; Brown, BW; Joshi, A; Masek, MA; Weiss, LM	1
McMaster, P; Mirza, DF	1
Broelsch, CE; Burdelski, M; Malagó, M; Rogiers, X; Wadström, J	1
Menezes, J; Tanner, JE	1
Okano, M; Purtilo, DT; Taguchi, Y	1
Brousse, N; Canioni, D; de Saint Sauveur, N; Goulet, O; Jan, D; Rambaud, C; Revillon, Y; Ricour, C	1
Madden, BP	1
Petri, WA	1
Bronster, DJ; Emre, S; Miller, CM; Mor, E; Schwartz, ME; Sheiner, P	1
Ghent, C; Grant, D; McAlister, V; Roy, A; Wall, W; Yilmaz, Z	1
Arellano, F; Krupp, P	1
Griesmacher, A; Grimm, M; Klepetko, W; Müller, MM; Vogl, M	1
Aziz, S; Haigh, WG; Oda, D; Penn, I; Persson, GR; Sabath, DE	1
Doolittle, G; Dorr, V; Woodroof, J	1
Baran, D; Gascon-Barré, M; Vendeville, B	1
Kaplan, B; Kaufman, D; Shaw, LM	1
Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N	1
Aswad, S; Burdick, J; Burrows, L; Danovitch, GM; Deierhoi, MH; Delmonico, FL; Freeman, RB; Gordon, JH; Laskow, D; Mendez, R; Munn, SR; Neylan, J; Pirsch, JD; Rohrer, RJ; Schwartz, B; Shaffer, D; Simpson, MA; Sollinger, H; Thistlethwaite, JR; Vincenti, F; Whelchel, J; Wiesner, RH; Wilkinson, AH; Woodle, ES	1
Cavallo, R; Giacchino, F; Merlino, C; Negro Ponzi, A; Re, D; Segoloni, G; Sinesi, F; Tognarelli, G	1
Alfieri, C; Tanner, JE	1
Boulad, F; Brochstein, JA; Castro-Malaspina, H; Childs, BH; Gillio, AP; Kernan, NA; Laver, J; O'Reilly, RJ; Reyes, B; Small, TN	1
Alonso, EM; Kelly, SM; Newell, KA; Rubin, CM; Thistlethwaite, JR; Whitington, PF	1
Berquist, WE; Cacciarelli, TV; Concepcion, W; Cox, KL; Esquivel, CO; Hammer, GB; Moore, DH; So, SK	1
Brown, S; Kryscio, R; Lucas, BA; McKeown, JW; Skeeters, LJ; Thompson, JS; Waid, TH	1
Miller, WT; Montone, KT; Siegel, SG	1
Johnston, TD; Nagabhuskahn, M; Ranjan, D; Siquijor, A; Wu, G	1
Azoulay, D; Bismuth, H; Debuire, B; Frenoy, N; Lemoine, A; Pham, H; Reynès, M; Salvucci, M; Samuel, D	1
Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, A; Pileggi, F; Stolf, N; Uip, D; Vieira, ML	1
Coles, JG; McCrindle, BW; Walker, RE; West, LJ	1
Born, G; Froschauer, R; Gralka, S; Hohenberger, W; Köckerling, F; Müller, V; Ott, R; Reck, T	1
Levy, GA	1
Niaudet, P	1
Bee, CS; Grosso, LE	1
Barnett, MJ; Chhanabhai, M; Fung, HC; Gascoyne, RD; Hogge, DE; Klingemann, HG; Le, A; Micallef, IN; Nantel, SH; Nevill, TJ; Shepherd, JD; Sutherland, HJ; Toze, CL	1
Egashira, M; Kaneko, T; Kawamata, N; Oshimi, K; Sugimoto, K	1
Appleby, MW; Brunkow, ME; Clark, LB; Ramsdell, F; Wilkinson, JE; Ziegler, SF	1
Berquist, WE; Castillo, RO; Cox, KL	1
Pirsch, JD	1
Nevins, TE	1
Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H	1
Dunn, S	1
Colonna, J; Heyman, M; Howell, C; Kennedy, AS; Koffman, BH	1
Doron, D; Granot, E; Morag, R	1
Ament, ME; Busuttil, RW; Goss, JA; Martin, MG; McDiarmid, SV; Vargas, JH; Younes, BS	1
Fabel, H; Harringer, W; Haverich, A; Hoeper, MM; Hoffmeyer, F; Niedermeyer, J; Spiekerkötter, E	1
Iwasaki, H; Kondo, H; Narita, K; Watanabe, J	1
Dominguez, J; Kiberd, B; MacDonald, AS; Mahalati, K; McAlister, VC	1
Kasper, RC; LeBoit, PE; Nihal, M; Wood, GS	1
Bumgardner, GL; Hardie, I; Johnson, RW; Lin, A; Nashan, B; Pescovitz, MD; Ramos, E; Vincenti, F	1
Jain, A; Mazariegos, GV; Reyes, J; Salzedas, AA	1
Inoue, M; Kawa, K; Nakayama, M; Okamura, T; Takeuchi, M; Yagi, K	1
Amenábar, JJ; Gaínza, FJ; Gómez-Ullate, P; Lampreabe, I; Urbizu, JM; Zárraga, S	1
Bach, JF; de The, G; Feutren, G	1
Cameron, EC; Chui, A; Karim, M; Keown, PA; Landsberg, D; McBride, M; Melosky, B; Shackleton, C; Yeung, CK	1
Diaz-Mitoma, F; Mirzayans, F; Preiksaitis, JK; Roberts, S; Tyrrell, DL	1
Burtin, P; Guerci, AP; Lederlin, P; Mattei, S	1
Fisher, GL; Mihatsch, MJ; Ryffel, B	1
Appolinaire-Pilipenko, S; Dueymes, M; Fournié, GJ; In, S; Labarre, JF; Sournies, F	1
Gunn, HC; Hiestand, PC	1

Reviews

22 review(s) available for cyclosporine and Duncan Disease

Article	Year
T-cell co-stimulatory blockade in transplantation: two steps forward one step back! Expert opinion on biological therapy, 2013, Volume: 13, Issue:11 Topics: Abatacept; Animals; B7-1 Antigen; B7-2 Antigen; CD28 Antigens; Clinical Trials as Topic; Costimulatory and Inhibitory T-Cell Receptors; Cyclosporine; Disease Susceptibility; Graft Enhancement, Immunologic; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunologic Memory; Immunosuppressive Agents; Infections; Kidney Diseases; Lymphocyte Activation; Lymphoproliferative Disorders; Molecular Targeted Therapy; Multicenter Studies as Topic; Postoperative Complications; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Th17 Cells; Transplantation Immunology	2013
Risk of posttransplant lymphoproliferative disorder associated with use of belatacept. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Nov-15, Volume: 70, Issue:22 Topics: Abatacept; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Patient Education as Topic; Patient Selection; Risk; Risk Management	2013
[Recent issues and prospects of the treatment of aplastic anemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:1 Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Benzoates; Biomarkers; Cyclosporine; Drug Therapy, Combination; Herpesvirus 4, Human; Humans; Hydrazines; Immunosuppressive Agents; Lymphoproliferative Disorders; Prednisolone; Pyrazoles; Receptors, Thrombopoietin; Risk; Severity of Illness Index; Thrombopoietin	2014
Belatacept for kidney transplant recipients. The Cochrane database of systematic reviews, 2014, Nov-24, Issue:11 Topics: Abatacept; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Basiliximab; Calcineurin Inhibitors; Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Prednisone; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Sirolimus; Tacrolimus	2014
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature. Leukemia & lymphoma, 2012, Volume: 53, Issue:3 Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia	2012
Comparative tolerability of systemic treatments for plaque-type psoriasis. Drug safety, 2002, Volume: 25, Issue:13 Topics: Acitretin; Cyclosporine; Dermatologic Agents; Drug Combinations; Eye Diseases; Humans; Keratolytic Agents; Liver Cirrhosis; Lymphoproliferative Disorders; Methotrexate; Nausea; Pancytopenia; Pneumonia; Pruritus; Psoriasis; PUVA Therapy; Skin Neoplasms	2002
Malignancy after transplantation. Transplantation, 2005, Oct-15, Volume: 80, Issue:2 Suppl Topics: Azathioprine; Calcineurin Inhibitors; Carcinoma, Hepatocellular; Cyclosporine; Hepatitis, Viral, Human; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Neoplasms; Sirolimus; Skin Neoplasms; Tacrolimus; Transplantation Immunology; Transplantation, Homologous	2005
The role of proliferation signal inhibitors in post-transplant malignancies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22 Suppl 1 Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Neoplasms; Protein Kinases; PTEN Phosphohydrolase; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2007
Malignancies in renal transplantation: an unmet medical need. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22 Suppl 1 Topics: Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Neoplasms; Risk Factors	2007
[Malignant tumors following renal transplantation]. Orvosi hetilap, 2007, Nov-11, Volume: 148, Issue:45 Topics: Adrenal Cortex Hormones; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Neoplasms; Prognosis; Sarcoma, Kaposi; Skin Neoplasms; Tacrolimus	2007
Optimal use of cyclosporin A in liver transplantation. Transplantation proceedings, 1994, Volume: 26, Issue:5 Topics: Biological Availability; Cyclosporine; Humans; Liver Transplantation; Lymphoproliferative Disorders; Postoperative Complications	1994
Infections in heart transplant recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:2 Topics: Anti-Bacterial Agents; Arteriosclerosis; Central Nervous System Diseases; Cyclosporine; Cytomegalovirus Infections; Heart Transplantation; Heart-Assist Devices; Humans; Infections; Lymphoproliferative Disorders; Pneumonia; Time Factors; Tissue Donors	1994
Neurologic complications of orthotopic liver transplantation. The Mount Sinai journal of medicine, New York, 1994, Volume: 61, Issue:1 Topics: Cerebrovascular Disorders; Cyclosporine; Humans; Liver Transplantation; Lymphoproliferative Disorders; Nervous System Diseases	1994
Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clinical chemistry, 1996, Volume: 42, Issue:8 Pt 2 Topics: Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Kidney Diseases; Lymphoproliferative Disorders; Organ Transplantation; Tacrolimus	1996
Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease. Leukemia & lymphoma, 1996, Volume: 21, Issue:5-6 Topics: Animals; B-Lymphocytes; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cocarcinogenesis; Cyclosporine; Gene Expression Regulation; Genes, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Interleukin-6; Lymphocyte Subsets; Lymphoma; Lymphoproliferative Disorders; Mice; Mice, Nude; Monocytes; Neoplasm Proteins; Postoperative Complications; Transplantation; Tumor Virus Infections; Viral Proteins; Virus Activation	1996
Neoral is superior to FK 506 in liver transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Cyclosporine; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Survival Rate; Tacrolimus	1998
Overview of new immunosuppressive therapies. Current opinion in pediatrics, 2000, Volume: 12, Issue:2 Topics: Child; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Mycophenolic Acid; Sirolimus; Tacrolimus	2000
Neoral use in the pediatric transplant recipient. Transplantation proceedings, 2000, Volume: 32, Issue:3A Suppl Topics: Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Organ Transplantation; Postoperative Complications; Risk Factors; Steroids; Treatment Outcome	2000
Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients. Paediatric drugs, 2001, Volume: 3, Issue:9 Topics: Child; Cyclosporine; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Tacrolimus	2001
[Presentation of cancers in recipients of a solid-organ transplant]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2001, Volume: 21, Issue:6 Topics: Carcinogens; Cell Transformation, Neoplastic; Cyclosporine; Genetic Predisposition to Disease; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Melanoma; Neoplasm Metastasis; Neoplasms; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Oncogenes; Postoperative Complications; Prevalence; Recurrence; Risk; Sarcoma, Kaposi; Skin Neoplasms; Transplantation; Tumor Virus Infections; Ultraviolet Rays	2001
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression. Journal of the American Society of Nephrology : JASN, 1992, Volume: 2, Issue:12 Suppl Topics: Actuarial Analysis; Antilymphocyte Serum; Azathioprine; Carcinoma; Cyclosporine; Graft Survival; Herpesviridae Infections; Humans; Immunosuppression Therapy; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Postoperative Complications; Prednisone; Prevalence; Registries; Retrospective Studies; Risk; Skin Neoplasms; Tumor Virus Infections	1992
Immunosuppression and cancer: the ciclosporin case. Drug and chemical toxicology, 1992, Volume: 15, Issue:2 Topics: Animals; Carcinogens; Cyclosporine; Humans; Immunosuppression Therapy; Lymphoproliferative Disorders; Risk Factors	1992

Trials

17 trial(s) available for cyclosporine and Duncan Disease

Article	Year
Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:11 Topics: Abatacept; Adult; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoconjugates; Immunosuppressive Agents; International Agencies; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Prognosis; Safety; Time Factors	2013
Long-term exposure to belatacept in recipients of extended criteria donor kidneys. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:11 Topics: Abatacept; Cohort Studies; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Humans; Immunoconjugates; Immunosuppressive Agents; International Agencies; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lipids; Lymphoproliferative Disorders; Male; Maximum Tolerated Dose; Middle Aged; Postoperative Complications; Prognosis; Safety; Time Factors; Tissue Donors	2013
Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 69, Issue:5 Topics: Abatacept; Adult; Calcineurin Inhibitors; Cyclosporine; Drug Substitution; Female; Graft Rejection; Graft Survival; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mortality; Neoplasms; Tacrolimus; Treatment Outcome	2017
Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder. Transplantation, 2008, Jul-27, Volume: 86, Issue:2 Topics: Acyclovir; Adult; Aged; Antineoplastic Agents; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Postoperative Complications; Recombinant Proteins; Remission Induction; Tacrolimus	2008
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:3 Topics: Abatacept; Adult; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Immunoconjugates; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Risk Factors; Time Factors	2010
Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2012, Volume: 12, Issue:3 Topics: Abatacept; Adult; Cyclosporine; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Postoperative Complications; Prognosis; Risk Factors; Survival Rate	2012
Incidence of PTLD in pediatric renal transplant recipients receiving basiliximab, calcineurin inhibitor, sirolimus and steroids. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2008, Volume: 8, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Basiliximab; Child; Child, Preschool; Cyclosporine; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Infant; Kidney Transplantation; Lymphoproliferative Disorders; Male; Multivariate Analysis; Postoperative Complications; Recombinant Fusion Proteins; Sirolimus; Tacrolimus	2008
Therapy with FK 506 in pediatric liver recipients. Transplantation proceedings, 1994, Volume: 26, Issue:1 Topics: Adolescent; Bilirubin; Child; Child, Preschool; Cyclosporine; Female; Graft Survival; Humans; Hyperkalemia; Immunosuppression Therapy; Infant; Infections; Liver Transplantation; Lymphoproliferative Disorders; Male; Safety; Tacrolimus	1994
Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood, 1995, Oct-01, Volume: 86, Issue:7 Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Whole-Body Irradiation	1995
Two-year experience with FK 506 in pediatric patients. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 1 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Intestine, Small; Liver Transplantation; Lung Transplantation; Lymphoproliferative Disorders; Prednisone; Survival Analysis; Tacrolimus	1993
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation, 1996, Sep-15, Volume: 62, Issue:5 Topics: Acute Disease; Adult; Cyclosporine; Cytomegalovirus Infections; Drug Resistance; Evaluation Studies as Topic; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Tacrolimus; Treatment Outcome	1996
Treatment of renal allograft rejection with T10B9.1A31 or OKT3: final analysis of a phase II clinical trial. Transplantation, 1997, Jul-27, Volume: 64, Issue:2 Topics: Adult; Antibodies; Antibodies, Monoclonal; Cyclosporine; Cytokines; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Muromonab-CD3; Survival Rate; Transplantation, Homologous; Virus Diseases	1997
Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression. Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 1998, Volume: 4, Issue:2 Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclosporine; Female; Humans; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Paraproteinemias; Tacrolimus	1998
Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. Transplantation, 1999, Oct-27, Volume: 68, Issue:8 Topics: Cyclosporine; Cytomegalovirus Infections; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoproliferative Disorders; Multivariate Analysis; Opportunistic Infections; Postoperative Complications; Tacrolimus	1999
Azathioprine withdrawal in stable lung and heart/lung recipients receiving cyclosporine-based immunosuppression. Transplantation, 2000, Aug-15, Volume: 70, Issue:3 Topics: Acute Disease; Adult; Azathioprine; Bronchiolitis Obliterans; Cyclosporine; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Prospective Studies; Respiratory Function Tests; Safety	2000
Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation. Transplantation, 2001, Sep-15, Volume: 72, Issue:5 Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Daclizumab; Graft Rejection; Graft Survival; Humans; Immunoglobulin G; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Neoplasms; Receptors, Interleukin-2; Survival Rate; Time Factors	2001
Epstein-Barr virus serology and isoelectrofocusing pattern of serum immunoglobulins in cyclosporin or placebo-treated type I diabetics. Journal of autoimmunity, 1992, Volume: 5, Issue:2 Topics: Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Autoimmune Diseases; Blood Protein Electrophoresis; Capsid Proteins; Cyclosporine; Diabetes Mellitus, Type 1; Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulins; Immunosuppression Therapy; Isoelectric Focusing; Lymphoma, B-Cell; Lymphoproliferative Disorders; Random Allocation; Single-Blind Method; Tumor Virus Infections	1992

Other Studies

99 other study(ies) available for cyclosporine and Duncan Disease

Article	Year
In vitro and in vivo evidence that the switch from calcineurin to mTOR inhibitors may be a strategy for immunosuppression in Epstein-Barr virus-associated post-transplant lymphoproliferative disorder. Kidney international, 2022, Volume: 102, Issue:6 Topics: Calcineurin; Cyclosporine; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphoproliferative Disorders; MTOR Inhibitors; Mycophenolic Acid; Prednisolone; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases	2022
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia. Frontiers in immunology, 2020, Volume: 11 Topics: Agammaglobulinemia; Age of Onset; Anemia, Hemolytic, Autoimmune; Child; Cyclosporine; Cytochrome P-450 CYP3A; Female; Gain of Function Mutation; Germ-Line Mutation; Graft vs Host Disease; Growth Disorders; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lymphoproliferative Disorders; Mutation, Missense; Polymorphism, Single Nucleotide; Prednisolone; Retinal Hemorrhage; Spectrin; STAT3 Transcription Factor; Unrelated Donors	2020
Remission of Late-Onset Post-Liver Transplantation Non-Hodgkin Lymphoma. Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki), 2019, May-01, Volume: 40, Issue:1 Topics: Adult; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Doxorubicin; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Prednisone; Remission Induction; Rituximab; Vincristine	2019
High graft protection and low incidences of infections, malignancies and other adverse effects with intra-operative high dose ATG-induction: a single centre cohort study of 760 cases. Annals of transplantation, 2013, Jan-10, Volume: 18 Topics: Adult; Antilymphocyte Serum; Azathioprine; Cohort Studies; Cyclosporine; Cytomegalovirus Infections; Female; Graft Survival; Humans; Immunosuppressive Agents; Intraoperative Period; Kaplan-Meier Estimate; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasms; Retrospective Studies; Steroids; T-Lymphocytes; Young Adult	2013
Clonal cytophagic histiocytic panniculitis in children may be cured by cyclosporine A. Pediatrics, 2013, Volume: 132, Issue:2 Topics: Biopsy, Needle; Bone Marrow; Chickenpox; Cyclosporine; Diagnosis, Differential; Female; Histiocytosis; Humans; Immunosuppressive Agents; Infant; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Macrophage Activation Syndrome; Male; Panniculitis; Respiratory Tract Infections; T-Lymphocytes	2013
Are regimens containing rituximab effective in the initial treatment of Epstein-Barr virus-positive natural killer cell lymphoproliferative disease-associated hemophagocytic lymphohistiocytosis? International journal of hematology, 2013, Volume: 98, Issue:3 Topics: Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Drug Therapy, Combination; Etoposide; Humans; Immunologic Factors; Immunosuppressive Agents; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Middle Aged; Prednisolone; Rituximab; Time Factors	2013
Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2015, Volume: 15, Issue:6 Topics: Adult; Biopsy; Cyclosporine; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Graft Rejection; Humans; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors	2015
Effect of Irradiation on Incidence of Post-Transplant Lymphoproliferative Disorder after Hematopoietic Cell Transplantation in Miniature Swine. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:10 Topics: Animals; Calcineurin Inhibitors; Cyclosporine; Disease Models, Animal; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 1, Suid; Histocompatibility; Humans; Immunosuppressive Agents; L-Lactate Dehydrogenase; Lymphatic Irradiation; Lymphocyte Depletion; Lymphoproliferative Disorders; Swine; Swine Diseases; Swine, Miniature; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Tumor Virus Infections; Whole-Body Irradiation	2015
BIRC4 Mutation: An Important Rare Cause of Uveitis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:8 Topics: Adalimumab; Antirheumatic Agents; Child; Cyclosporine; Epstein-Barr Virus Infections; Genetic Diseases, X-Linked; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Mutation; Treatment Outcome; Uveitis; X-Linked Inhibitor of Apoptosis Protein	2015
Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency: The Karolinska Experience. Transplantation, 2016, Volume: 100, Issue:6 Topics: Adolescent; Adult; Child; Child, Preschool; Complement C1q; Cortisone; Cyclosporine; Fatal Outcome; Female; Gastrointestinal Diseases; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Heterozygote; Humans; Infant; Iraq; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Male; Methotrexate; Postoperative Complications; Rituximab; Sweden; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2016
Development of lymphoproliferative disease after liver transplantation. Transplantation proceedings, 2008, Volume: 40, Issue:9 Topics: Adult; Carcinoma, Squamous Cell; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Male; Retrospective Studies; Risk Factors; Skin Neoplasms; Survival Analysis; Survivors; Tacrolimus	2008
Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring. Pediatric transplantation, 2009, Volume: 13, Issue:5 Topics: Bronchoalveolar Lavage; Bronchoscopy; Case-Control Studies; Child; Cyclosporine; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lung Transplantation; Lymphoproliferative Disorders; Male; Monitoring, Physiologic; Postoperative Complications; Retrospective Studies; Viral Load	2009
Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy. Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Acyclovir; Adrenoleukodystrophy; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; Child; Child, Preschool; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclosporine; Epstein-Barr Virus Infections; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Remission Induction; Rituximab; Tumor Virus Infections; Virus Activation	2009
Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. Blood, 2009, Nov-26, Volume: 114, Issue:23 Topics: Adoptive Transfer; Calcineurin; Calcineurin Inhibitors; Cells, Cultured; Cyclophilin A; Cyclosporine; Cytotoxicity, Immunologic; Drug Resistance; Epstein-Barr Virus Infections; Genetic Vectors; Humans; Immunosuppressive Agents; Interferon-gamma; Jurkat Cells; Lymphoproliferative Disorders; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Organ Transplantation; Postoperative Complications; Protein Conformation; Protein Interaction Mapping; Recombinant Fusion Proteins; Retroviridae; T-Lymphocytes, Cytotoxic; Tacrolimus; Tacrolimus Binding Protein 1A	2009
Malignancy after heart transplantation. Journal of the Chinese Medical Association : JCMA, 2009, Volume: 72, Issue:11 Topics: Adolescent; Adult; Aged; Child; Cyclosporine; Heart Transplantation; Humans; Incidence; Lymphoproliferative Disorders; Middle Aged; Neoplasms; Risk Factors; Skin Neoplasms	2009
Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2010, Volume: 29, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cohort Studies; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Heart Transplantation; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Proportional Hazards Models; Recurrence; Risk Assessment; Tacrolimus; Time Factors; Viral Load; Young Adult	2010
Multiple clinical presentations of lymphoproliferative disorders in pediatric liver transplant recipients: a single-center experience. Transplantation proceedings, 2010, Volume: 42, Issue:5 Topics: Biliary Atresia; Child; Child, Preschool; Colonic Neoplasms; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Infant; Liver Transplantation; Lymph Nodes; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisone; Retrospective Studies; Survivors; Tacrolimus	2010
Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation, 2010, Dec-27, Volume: 90, Issue:12 Topics: Abatacept; Cyclosporine; Follow-Up Studies; Graft Survival; Humans; Immunoconjugates; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Risk Assessment; Survival Rate; Time Factors; Treatment Outcome	2010
Role of immunosuppression regimen in post-transplant lymphoproliferative disorder in pediatric heart transplant patients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2011, Volume: 30, Issue:4 Topics: Child; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Retrospective Studies; Risk Factors; Tacrolimus; Treatment Outcome	2011
Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:7 Topics: Adolescent; Aged; Antibodies, Viral; Azathioprine; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Hepatitis C; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Postoperative Complications; Steroids; Tacrolimus	2011
Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin. Transplantation proceedings, 2011, Volume: 43, Issue:5 Topics: Antibodies, Monoclonal, Murine-Derived; Calcineurin Inhibitors; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Rituximab; Sirolimus	2011
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. Transplantation, 2012, Jan-15, Volume: 93, Issue:1 Topics: Adolescent; Adult; Comorbidity; Cyclosporine; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Graft Rejection; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Kidney Transplantation; Longitudinal Studies; Lymphoproliferative Disorders; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Tacrolimus; TOR Serine-Threonine Kinases; Transplantation; Young Adult	2012
An Epstein-Barr virus-associated leukemic lymphoma in a patient treated with rabbit antithymocyte globulin and cyclosporine for hepatitis-associated aplastic anemia. Acta haematologica, 2012, Volume: 127, Issue:2 Topics: Acidosis, Lactic; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cyclosporine; DNA, Viral; Epstein-Barr Virus Infections; Fatal Outcome; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Middle Aged; Rabbits; Viral Load	2012
Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:11 Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Hemoglobinuria, Paroxysmal; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Multiple Organ Failure	2011
T-cell acute lymphoblastic leukaemia after liver transplantation: post-transplant lymphoproliferative disorder or coincidental de novo leukaemia? Hematological oncology, 2013, Volume: 31, Issue:1 Topics: Adolescent; Biliary Atresia; Causality; Clone Cells; Comorbidity; Cyclosporine; Diagnosis, Differential; Disease Susceptibility; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Leukemia, Radiation-Induced; Liver Transplantation; Lymphoproliferative Disorders; Male; Muromonab-CD3; Postoperative Complications; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Radiography; Remission Induction; Reoperation; Tacrolimus; Time Factors	2013
Effect of posaconazole on cyclosporine blood levels and dose adjustment in allogeneic blood and marrow transplant recipients. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:12 Topics: Adolescent; Adult; Aged; Antifungal Agents; Blood Transfusion; Bone Marrow Transplantation; Cyclosporine; Drug Interactions; Drug Monitoring; Female; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Lymphoproliferative Disorders; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Triazoles; Young Adult	2012
A retrospective analysis of long-term survival in severe aplastic anemia patients treated with allogeneic bone marrow transplantation or immunosuppressive therapy with antithymocyte globulin and cyclosporin A at a single institution. Military medicine, 2002, Volume: 167, Issue:7 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Child; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Transplantation, Homologous; Treatment Outcome	2002
Low incidence of posttransplant lymphoproliferative disease in children treated with low-dose immunosuppression after liver transplantation. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Child; Child, Preschool; Cyclosporine; DNA, Viral; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Prevalence; Retrospective Studies	2002
Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine. Transplantation proceedings, 2002, Volume: 34, Issue:5 Topics: Adolescent; Age Distribution; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Liver Diseases; Liver Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Reoperation; Retrospective Studies; Survival Analysis; Tacrolimus; Treatment Outcome	2002
Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. Blood, 2002, Nov-01, Volume: 100, Issue:9 Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Disease-Free Survival; Female; Graft vs Host Disease; Graft vs Tumor Effect; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Incidence; Infections; Life Tables; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prospective Studies; Spain; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; United Kingdom; Vidarabine	2002
Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:5 Topics: Adolescent; Adult; Antiviral Agents; Child; Cyclosporine; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Ganciclovir; Heart Transplantation; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Incidence; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis	2003
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:10 Topics: Adult; Age Factors; Case-Control Studies; Coronary Artery Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Multivariate Analysis; Obesity; Postoperative Complications; Risk Factors; Sex Factors; Time Factors	2003
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation, 2003, Nov-15, Volume: 76, Issue:9 Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Cyclosporine; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Interleukin-2; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Survival Analysis; Tacrolimus	2003
Low-dose immunosuppression reduces the incidence of post-transplant lymphoproliferative disease in pediatric liver graft recipients. Journal of pediatric gastroenterology and nutrition, 2004, Volume: 38, Issue:2 Topics: Adolescent; Child; Child, Preschool; Cyclosporine; DNA, Viral; Epstein-Barr Virus Infections; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Liver Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Retrospective Studies; Tacrolimus; Viral Load	2004
Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:8 Topics: Animals; B-Lymphocytes; Cell Transplantation; Cyclosporine; Disease Models, Animal; Flow Cytometry; Haplotypes; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Major Histocompatibility Complex; Polymerase Chain Reaction; Risk Factors; Swine; Swine, Miniature; T-Lymphocytes; Thymus Gland; Time Factors; Transplantation	2004
EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2004, Volume: 4, Issue:11 Topics: Aged; Antigens, CD; Antineoplastic Agents; Cyclosporine; Heart Transplantation; Herpesvirus 4, Human; HIV Seropositivity; Humans; Immunohistochemistry; Ki-1 Antigen; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Male; Postoperative Complications; RNA, Viral; Skin Neoplasms; Treatment Outcome	2004
Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression. Journal of the American Academy of Dermatology, 2005, Volume: 52, Issue:2 Suppl 1 Topics: B-Lymphocytes; Cyclosporine; Epstein-Barr Virus Infections; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Psoriasis; Remission, Spontaneous; Time Factors	2005
Ten year survival after paediatric heart transplantation: a single centre experience. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2005, Volume: 27, Issue:5 Topics: Azathioprine; Cardiomyopathies; Child; Child, Preschool; Coronary Angiography; Coronary Disease; Cyclosporine; Follow-Up Studies; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Lymphoproliferative Disorders; Survival Rate; Ultrasonography	2005
Long-term outcome of intractable ulcerating enterocolitis of infancy. Journal of pediatric gastroenterology and nutrition, 2005, Volume: 40, Issue:5 Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcerative; Cyclosporine; Enterocolitis; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Steroids; Thalidomide; Time Factors; Treatment Outcome	2005
Bilateral lacrimal gland enlargement due to post-transplant lymphoproliferative disorder. Eye (London, England), 2006, Volume: 20, Issue:8 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclosporine; Epstein-Barr Virus Infections; Humans; Immunohistochemistry; Immunologic Factors; Kidney Transplantation; Lacrimal Apparatus Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Rituximab	2006
Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation. Journal of pediatric hematology/oncology, 2005, Volume: 27, Issue:10 Topics: Adolescent; Animals; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Epstein-Barr Virus Infections; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Infant; Lymphoproliferative Disorders; Male; Rabbits; Retrospective Studies; Transplantation Conditioning	2005
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation. Haematologica, 2005, Volume: 90 Suppl Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Child; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Transfusion; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Rituximab; Time Factors; Transplantation Chimera; Transplantation Conditioning; Vincristine; Virus Activation; Whole-Body Irradiation	2005
Ten- and 20-year survivors of pediatric orthotopic heart transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2006, Volume: 25, Issue:3 Topics: Actuarial Analysis; Adolescent; Bacterial Infections; Cardiomyopathies; Child; Child, Preschool; Coronary Artery Disease; Cyclosporine; Female; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Reoperation; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus	2006
Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders. Bone marrow transplantation, 2006, Volume: 37, Issue:10 Topics: Adolescent; Adult; Aged; B-Lymphocytes; Cyclosporine; Female; Filgrastim; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Recombinant Proteins; Remission Induction; Transplantation, Homologous	2006
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. Haematologica, 2006, Volume: 91, Issue:5 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha	2006
[Clinicopathologic study of post-transplant lymphoproliferative disorders]. Zhonghua bing li xue za zhi = Chinese journal of pathology, 2006, Volume: 35, Issue:4 Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpesvirus 4, Human; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Ki-67 Antigen; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm Staging; Prognosis; RNA, Viral	2006
Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases. Transplantation proceedings, 2006, Volume: 38, Issue:5 Topics: Aged; Antibodies; Antigens, CD20; Cyclosporine; Epstein-Barr Virus Infections; Female; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus; Viral Load	2006
Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease. Arthritis and rheumatism, 2006, Oct-15, Volume: 55, Issue:5 Topics: Antirheumatic Agents; B-Lymphocytes; Cyclosporine; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human; Humans; Infant; Infant, Newborn; Inflammation; Lymphoproliferative Disorders; Rheumatic Diseases; Syndrome	2006
Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients. Transplantation, 2007, Mar-15, Volume: 83, Issue:5 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Metabolic Clearance Rate; Middle Aged; Mycophenolic Acid; Postoperative Complications; Retrospective Studies; Survival Analysis; Ventricular Function, Left	2007
Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2 Topics: ABO Blood-Group System; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; beta-Thalassemia; Blood Group Incompatibility; Busulfan; Child, Preschool; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasma Exchange; Red-Cell Aplasia, Pure; Remission, Spontaneous; Retrospective Studies; Risk Factors; Rituximab; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2007
Conjunctival posttransplantation lymphoproliferative disorder. American journal of ophthalmology, 2007, Volume: 143, Issue:6 Topics: Biomarkers; Bone Marrow Transplantation; Child; Conjunctival Diseases; Cyclosporine; DNA, Viral; Epstein-Barr Virus Infections; Eye Infections, Viral; Humans; Immunoenzyme Techniques; In Situ Hybridization; Lymphoproliferative Disorders; Male; Prednisone; T-Lymphocytes, Cytotoxic; Wiskott-Aldrich Syndrome	2007
[Diagnosis and treatment of de novo malignancy after liver transplantation]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2007, Volume: 29, Issue:3 Topics: Adult; Antiviral Agents; Colonic Neoplasms; Cyclosporine; Esophageal Neoplasms; Female; Ganciclovir; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Middle Aged; Pharyngeal Neoplasms; Survival Analysis; Tacrolimus; Time Factors	2007
Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients. Pediatrics, 2007, Volume: 120, Issue:3 Topics: Adrenal Cortex Hormones; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Immunotherapy; Infections; Injections, Spinal; Lymphohistiocytosis, Hemophagocytic; Lymphoproliferative Disorders; Male; Methotrexate; Methylprednisolone; Recurrence; Retrospective Studies; Treatment Outcome	2007
Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease. Pediatric transplantation, 2008, Volume: 12, Issue:4 Topics: Adolescent; Antineoplastic Agents; Child; Cyclosporine; Diagnosis, Differential; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymph Nodes; Lymphoproliferative Disorders; Male	2008
Posttransplant lymphoproliferative disease after heart transplantation on Sandimmune therapy: treatment with interferon alfa-2b and intravenous immunoglobulin. Transplantation proceedings, 1994, Volume: 26, Issue:5 Topics: Antigens, CD; beta 2-Microglobulin; Biomarkers; Cyclosporine; Granulocyte Colony-Stimulating Factor; Heart Transplantation; Humans; Immunoglobulins, Intravenous; Interferon alpha-2; Interferon-alpha; Lymphoproliferative Disorders; Receptors, IgE; Receptors, Interleukin-2; Recombinant Proteins	1994
An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation, 1995, Feb-27, Volume: 59, Issue:4 Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Liver Transplantation; Lymphoproliferative Disorders; Opportunistic Infections; Retrospective Studies; Tacrolimus; Tumor Virus Infections	1995
Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506. Journal of the American College of Cardiology, 1995, Volume: 25, Issue:5 Topics: Adolescent; Adult; Antihypertensive Agents; Azathioprine; Cardiac Catheterization; Child; Cyclosporine; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppression Therapy; Kidney Diseases; Lymphoproliferative Disorders; Prednisone; Tacrolimus; Time Factors	1995
A decade (1982 to 1992) of pediatric cardiac transplantation and the impact of FK 506 immunosuppression. The Journal of thoracic and cardiovascular surgery, 1993, Volume: 105, Issue:3 Topics: Adolescent; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Extracorporeal Membrane Oxygenation; Female; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Infections; Kidney; Lymphoproliferative Disorders; Male; Postoperative Complications; Tacrolimus	1993
Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR. Journal of immunology (Baltimore, Md. : 1950), 1993, Jul-15, Volume: 151, Issue:2 Topics: Animals; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Autoimmune Diseases; CD28 Antigens; CD4 Antigens; CD8 Antigens; Cyclosporine; Enterotoxins; Immune Tolerance; Interleukin-2; Leukocyte Common Antigens; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred C3H; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate	1993
"Quilty" revisited: a 10-year perspective. Human pathology, 1995, Volume: 26, Issue:5 Topics: Adolescent; Adult; Aging; Biopsy; Cardiomyopathies; Coronary Disease; Cyclosporine; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunohistochemistry; Lymphoid Tissue; Lymphoproliferative Disorders; Male; Myocardium; Postoperative Care; Postoperative Period; Sex Characteristics; Virus Diseases	1995
Optimal clinical regimens for living related liver transplantation. Transplantation proceedings, 1994, Volume: 26, Issue:5 Topics: Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Drug Administration Schedule; Family; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppression Therapy; Incidence; Infant; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Prednisolone; Retrospective Studies; Survival Rate; Time Factors; Tissue Donors; Virus Diseases	1994
Interleukin-6 and Epstein-Barr virus induction by cyclosporine A: potential role in lymphoproliferative disease. Blood, 1994, Dec-01, Volume: 84, Issue:11 Topics: Antigens, Viral; B-Lymphocytes; Cell Transformation, Viral; Cells, Cultured; Cyclosporine; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Immunocompromised Host; Interleukin-6; Ionomycin; Lymphoma, B-Cell; Lymphoproliferative Disorders; Monocytes; Polymerase Chain Reaction; Receptors, Complement 3d; Stimulation, Chemical; Tetradecanoylphorbol Acetate; Tumor Virus Infections; Viral Matrix Proteins; Virus Activation	1994
The effect of intravenous immunoglobulin and interferon-alpha on Epstein-Barr virus-induced lymphoproliferative disorder in a liver transplant recipient. Transplantation, 1994, Jun-27, Volume: 57, Issue:12 Topics: alpha 1-Antitrypsin Deficiency; Antigens, Viral; Capsid; Child, Preschool; Cyclosporine; DNA-Binding Proteins; Epstein-Barr Virus Nuclear Antigens; Female; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulin M; Immunoglobulins, Intravenous; Interferon-alpha; Liver Function Tests; Liver Transplantation; Lymphocytes; Lymphoproliferative Disorders; Prednisolone	1994
Small bowel transplant cyclosporine-related lymphoproliferative disorder: report of a case. Transplantation proceedings, 1994, Volume: 26, Issue:3 Topics: Child, Preschool; Cyclosporine; Genes, Viral; Graft Rejection; Herpesvirus 4, Human; Humans; Ileum; Intestine, Small; Lymphoproliferative Disorders; Male; Short Bowel Syndrome; Transplantation, Homologous	1994
Late complications after cardiac transplantation. British heart journal, 1994, Volume: 72, Issue:1 Topics: Cyclosporine; Cytomegalovirus Infections; Drug Interactions; Heart Transplantation; Humans; Lymphoproliferative Disorders; Opportunistic Infections; Postoperative Complications; Time Factors	1994
Posttransplant lymphoproliferative disorders in liver recipients treated with OKT3 or ALG induction immunosuppression. Transplantation proceedings, 1993, Volume: 25, Issue:1 Pt 2 Topics: Adult; Antilymphocyte Serum; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Humans; Incidence; Liver Transplantation; Lymphoproliferative Disorders; Male; Muromonab-CD3; Prednisolone; Retrospective Studies; Time Factors	1993
Malignancies in rheumatoid arthritis patients treated with cyclosporin A. British journal of rheumatology, 1993, Volume: 32 Suppl 1 Topics: Aged; Arthritis, Rheumatoid; Cyclosporine; Female; Humans; Immunosuppression Therapy; Incidence; Leukemia; Lymphoproliferative Disorders; Male; Middle Aged; Risk Factors	1993
Tissue polypeptide specific antigen for the detection of lymphoproliferative diseases induced by cyclosporin. Journal of clinical pathology, 1995, Volume: 48, Issue:11 Topics: Adult; Biomarkers, Tumor; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunocompromised Host; Lung Transplantation; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Peptides; Postoperative Complications; Retrospective Studies	1995
Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation, 1996, Feb-15, Volume: 61, Issue:3 Topics: Adult; Base Sequence; Cyclosporine; DNA Primers; DNA, Viral; Gingival Hyperplasia; Heart Transplantation; Herpesvirus 4, Human; Humans; Immunoglobulin Heavy Chains; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Molecular Sequence Data; Risk Factors	1996
First report of a B cell lymphoproliferative disorder arising in a patient treated with immune suppressants for severe aplastic anemia. American journal of hematology, 1996, Volume: 52, Issue:2 Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; B-Lymphocytes; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukocyte Count; Lymphoproliferative Disorders; Platelet Count	1996
Effects of vitamin D3 and cyclosporin A on HgCl2-induced autoimmunity in brown Norway rats. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:11 Topics: Animals; Autoimmune Diseases; Autoimmunity; Calcium; Cholecalciferol; Cyclosporine; Drug Therapy, Combination; Female; Glomerulonephritis; Immunoglobulin E; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Mercuric Chloride; Proteinuria; Rats; Rats, Inbred BN; Serum Albumin	1995
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience. Bone marrow transplantation, 1996, Volume: 17 Suppl 2 Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation	1996
[Epstein-Barr virus infection and lymphoproliferative disorders in patients after renal transplantation]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 1996, Volume: 48, Issue:3 Topics: Adult; Antibodies, Viral; Cyclosporine; Cytomegalovirus Infections; Female; Glucocorticoids; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Postoperative Complications	1996
Comparison of long-term outcome of children with severe aplastic anemia treated with immunosuppression versus bone marrow transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1997, Volume: 3, Issue:1 Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cause of Death; Child; Child, Preschool; Cohort Studies; Cyclosporine; Female; Graft vs Host Disease; Histocompatibility; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Nuclear Family; Remission, Spontaneous; Retrospective Studies; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation, Homologous; Treatment Outcome	1997
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children. The Journal of pediatrics, 1997, Volume: 131, Issue:1 Pt 1 Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Follow-Up Studies; Ganciclovir; Glucocorticoids; Graft Rejection; Herpesviridae Infections; Herpesvirus 4, Human; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Incidence; Liver Failure; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Muromonab-CD3; Prednisone; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus; Tumor Virus Infections	1997
Factors affecting survival after orthotopic liver transplantation in infants. Transplantation, 1997, Jul-27, Volume: 64, Issue:2 Topics: Aging; Antilymphocyte Serum; Cause of Death; Cyclosporine; Graft Rejection; Graft Survival; Humans; Infant; Liver Transplantation; Lymphoproliferative Disorders; Portal Vein; Retrospective Studies; Survival Rate; Thrombosis	1997
Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population. Critical reviews in diagnostic imaging, 1997, Volume: 38, Issue:6 Topics: Abdomen; Adolescent; Adult; Brain Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphoma; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Muromonab-CD3; Radiography, Abdominal; Retrospective Studies; Survival Rate; Thoracic Diseases; Tomography, X-Ray Computed	1997
The effect of curcumin on human B-cell immortalization by Epstein-Barr virus. The American surgeon, 1998, Volume: 64, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; B-Lymphocytes; Cell Transformation, Viral; Cells, Cultured; Curcumin; Cyclosporine; Dose-Response Relationship, Drug; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Oxidative Stress	1998
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 1998, Volume: 17, Issue:4 Topics: Adult; Carcinoma, Squamous Cell; Chagas Cardiomyopathy; Chemoprevention; Chronic Disease; Cocarcinogenesis; Cyclosporine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Lung Diseases; Lymphoproliferative Disorders; Male; Mutagens; Neoplasms; Neurilemmoma; Nitroimidazoles; Recurrence; Sarcoma, Kaposi; Skin Neoplasms; Survival Rate; Trypanocidal Agents	1998
Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:4 Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Heart Transplantation; Humans; Hyperglycemia; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Medical Records; Prednisone; Retrospective Studies; Tacrolimus	1998
Low rejection rate after hepatic transplantation achieved with a cyclosporine-based quadruple immunosuppressive regimen. Transplantation proceedings, 1998, Volume: 30, Issue:4 Topics: Adult; Antilymphocyte Serum; Cyclosporine; Cytomegalovirus Infections; Drug Monitoring; Drug Therapy, Combination; Graft Rejection; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Incidence; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoproliferative Disorders; Methylprednisolone; Monitoring, Immunologic; Neoplasms, Second Primary; Opportunistic Infections; Postoperative Complications; Retrospective Studies	1998
Postransplant lymphoproliferative disease following renal transplantation: a multicenter retrospective study of 41 cases observed between 1992 and 1996. French Speaking Transplantation Workshop. Transplantation proceedings, 1998, Volume: 30, Issue:6 Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunophenotyping; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphoma; Lymphoproliferative Disorders; Postoperative Complications; Retrospective Studies; Survival Analysis	1998
T-cell rich, Ki-1-positive post-transplant lymphoproliferative disorder: a previously undescribed variant following liver transplant. Pathology, 1998, Volume: 30, Issue:4 Topics: Cyclosporine; DNA; Fatal Outcome; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunophenotyping; Immunosuppressive Agents; Ki-1 Antigen; Liver Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Prednisolone; T-Lymphocytes	1998
Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience. Bone marrow transplantation, 1998, Volume: 22, Issue:10 Topics: Adolescent; Adult; Animals; Antibodies, Monoclonal; Antilymphocyte Serum; Bone Marrow Transplantation; British Columbia; Child; Cyclosporine; Female; Humans; Immunophenotyping; Immunosuppressive Agents; Immunotoxins; Lymphoproliferative Disorders; Male; Middle Aged; Rabbits; Retrospective Studies; Ricin; Risk Factors; Transplantation, Homologous	1998
P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood, 1999, Jan-15, Volume: 93, Issue:2 Topics: Adult; Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD56 Antigen; Cell Line; Child; Cyclosporine; Cyclosporins; Female; Gene Expression; Genes, MDR; Humans; Immunosuppressive Agents; Killer Cells, Natural; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoproliferative Disorders; Male; Middle Aged; Receptors, IgG; Reverse Transcriptase Polymerase Chain Reaction	1999
Cellular and molecular characterization of the scurfy mouse mutant. Journal of immunology (Baltimore, Md. : 1950), 1999, Mar-01, Volume: 162, Issue:5 Topics: Abatacept; Animals; Antigens, CD; Antigens, Differentiation; B7-1 Antigen; Benzoquinones; CTLA-4 Antigen; Cyclosporine; Female; Genistein; Granulocyte-Macrophage Colony-Stimulating Factor; Immunoconjugates; Lactams, Macrocyclic; Leukocyte Common Antigens; Lymphocyte Activation; Lymphoproliferative Disorders; Male; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Nuclear Proteins; Quinones; Receptors, Antigen, T-Cell; Rifabutin; T-Lymphocytes; Transcription Factors	1999
Paediatric liver transplantation: indications, timing and medical complications. Journal of gastroenterology and hepatology, 1999, Volume: 14 Suppl Topics: Adolescent; Adult; Age Factors; Biliary Atresia; Child; Child, Preschool; Cyclosporine; Hepatic Encephalopathy; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Postoperative Complications; Tacrolimus	1999
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity. British journal of haematology, 2000, Volume: 108, Issue:4 Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous	2000
Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation. International journal of cancer, 2000, Apr-20, Volume: 90, Issue:2 Topics: Algorithms; Cyclosporine; Epstein-Barr Virus Infections; Female; Graft Rejection; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Lymphoma, B-Cell; Lymphoproliferative Disorders; Middle Aged; Prednisone; Tomography, X-Ray Computed	2000
Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation. Transplantation proceedings, 2000, Volume: 32, Issue:4 Topics: Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Child; Child, Preschool; Cyclosporine; Female; Herpesvirus 4, Human; Humans; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Liver Transplantation; Lymphoproliferative Disorders; Male; Monitoring, Physiologic; Postoperative Complications; Tacrolimus	2000
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation, 2000, Jul-15, Volume: 70, Issue:1 Topics: Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Incidence; Infant; Liver Transplantation; Lymphoproliferative Disorders; Muromonab-CD3; Retrospective Studies; Risk Factors; Tacrolimus	2000
Effectiveness of cyclosporin A in a patient with pure red cell aplasia associated with T cell-lineage granular lymphocyte proliferative disorders resistant to cyclophosphamide therapy. European journal of haematology, 2000, Volume: 64, Issue:3 Topics: Aged; Biopsy; Bone Marrow; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Lymphoproliferative Disorders; Red-Cell Aplasia, Pure; T-Lymphocytes	2000
Conversion to rapamycin immunosuppression in renal transplant recipients: report of an initial experience. Transplantation, 2000, Oct-27, Volume: 70, Issue:8 Topics: Adult; Blood Pressure; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Pneumonia; Sirolimus; Tacrolimus	2000
Anetoderma arising in cutaneous B-cell lymphoproliferative disease. The American Journal of dermatopathology, 2001, Volume: 23, Issue:2 Topics: Adult; Atrophy; Cutis Laxa; Cyclosporine; DNA; Elastic Tissue; Female; Fluorescein-5-isothiocyanate; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; In Situ Hybridization; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Polymerase Chain Reaction; RNA, Viral; Skin Neoplasms; Tacrolimus	2001
Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood, 2001, Nov-15, Volume: 98, Issue:10 Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Culicidae; Cyclosporine; Epstein-Barr Virus Infections; Female; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Hypersensitivity; Immunocompromised Host; Immunosuppressive Agents; Insect Bites and Stings; Killer Cells, Natural; Lymphoproliferative Disorders; Male; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Antigen, T-Cell, gamma-delta; Remission Induction; Skin; T-Lymphocyte Subsets; Virus Activation	2001
Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. The Journal of infectious diseases, 1992, Volume: 166, Issue:5 Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; DNA, Viral; Female; Follow-Up Studies; Genotype; Graft Rejection; Heart Transplantation; Heart-Lung Transplantation; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoproliferative Disorders; Male; Methylprednisolone; Middle Aged; Mouth; Pharynx; Polymerase Chain Reaction; Prednisone; Risk Factors; Time Factors; Transplantation, Homologous	1992
[Lymphoproliferative syndromes after cardiac transplantation and treatment with cyclosporine. Report of 4 cases]. Annales de medecine interne, 1992, Volume: 143, Issue:3 Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Multiple Myeloma; Prednisolone; Risk	1992
Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A. Journal of clinical & laboratory immunology, 1990, Volume: 32, Issue:2 Topics: Age Factors; Albuminuria; Animals; Antibody Formation; Aziridines; Cyclosporine; Hypergammaglobulinemia; Immunoglobulins; Immunosuppressive Agents; Lupus Nephritis; Lymphoproliferative Disorders; Mice; Mice, Mutant Strains; Organophosphorus Compounds; Sodium Chloride; Structure-Activity Relationship	1990
Cyclosporine A and cyclosporine G enhance IgG rheumatoid factor production in MRL/lpr mice. Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 4 Topics: Animals; Antibodies, Antinuclear; Cyclosporine; Cyclosporins; Immunoglobulin G; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphoid Tissue; Lymphoproliferative Disorders; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Organ Size; Rheumatoid Factor; Stimulation, Chemical	1988